Skip to Content

After the Supreme Court’s Roundup Decision, Can People Diagnosed With Non-Hodgkin Lymphoma Still File Claims?

Looking down at a pump sprayer on wet concrete

Headlines about the Supreme Court’s Roundup decision may have left people with the impression that Roundup lawsuits are over. That is not what happened.

The Supreme Court’s 2026 decision in Monsanto v. Durnell narrowed one legal theory involving Roundup warning labels. It did not declare Roundup safe, determine whether glyphosate causes non-Hodgkin lymphoma, or eliminate every potential claim against Monsanto.

For people diagnosed with non-Hodgkin lymphoma after significant Roundup exposure, legal options may still exist.

What Did the Supreme Court Decide About Roundup Lawsuits?

The Supreme Court focused on whether state-law failure-to-warn claims could proceed when the Environmental Protection Agency had not required a cancer warning on glyphosate products.

The Court held that the Federal Insecticide, Fungicide, and Rodenticide Act, or FIFRA, preempts certain state-law claims that would effectively require Monsanto to use labeling different from what federal regulators approved.

That ruling is significant, but limited.

The Court did not decide whether Roundup causes cancer. It also did not eliminate every legal theory available to people who developed non-Hodgkin lymphoma after using Roundup.

Thousands of Roundup cases remain active in federal and state courts, and courts are continuing to determine how the Supreme Court ruling applies to different types of claims.

What Roundup Claims May Still Be Available?

Not every product liability lawsuit is based on a warning label.

Design defect claims, for example, focus on whether a product itself was unreasonably dangerous. In Roundup litigation, plaintiffs may argue that the formulation of glyphosate with other ingredients created unreasonable risks or that safer alternatives were available.

Other claims may focus on Monsanto’s conduct, including allegations involving inadequate testing, fraudulent concealment, or misleading communications about Roundup and glyphosate.

These theories raise different questions than a failure-to-warn claim because they may concern product design, testing practices, corporate conduct, or alleged misrepresentations rather than the wording printed on a Roundup label.

Courts are now examining these issues claim by claim. That makes the facts surrounding an individual’s exposure, diagnosis, and potential legal theories increasingly important.

What Does the Proposed Roundup Settlement Mean for Current Claims?

Separate from the Supreme Court decision, Bayer has pursued a proposed $7.25 billion settlement involving many current and future Roundup non-Hodgkin lymphoma claims.

The proposal does not necessarily resolve every Roundup lawsuit. Questions remain regarding final approval, who may be covered, available compensation, and how the settlement could affect cases filed in different courts.

For someone diagnosed with non-Hodgkin lymphoma, the existence of a proposed settlement should not be confused with an automatic payout or the end of individual Roundup litigation.

Is It Too Late to File a Roundup Lawsuit?

One of the most important questions for potential Roundup claimants is timing.

Every state has its own statute of limitations. In toxic exposure and product liability cases, determining when that deadline begins can be complicated because diseases such as non-Hodgkin lymphoma may develop years after exposure.

Depending on state law, the filing period may be connected to when a person was diagnosed or when they knew, or reasonably should have known, that their illness might be associated with Roundup exposure.

Other legal doctrines, including fraudulent concealment tolling, may also affect the deadline in certain circumstances.

Because these rules vary significantly by state, someone who used Roundup years ago should not assume that an older exposure automatically prevents them from pursuing a claim.

Can You Still File a Roundup Non-Hodgkin Lymphoma Lawsuit in 2026?

Potentially. The Supreme Court changed the Roundup litigation landscape, but it did not close the courthouse doors to everyone diagnosed with non-Hodgkin lymphoma after Roundup exposure.

What matters now is the specific legal theory, the person’s history of Roundup use, medical diagnosis, applicable state law, and filing deadline.

At Farrell & Fuller, we take on complex mass tort litigation against powerful corporate defendants and stay directly involved with the people we represent. If you have questions about how the Supreme Court’s Roundup decision may affect your circumstances, a conversation with our team can help clarify your options.

Categories: 

get help now

Connect with a Real Person – We're Here for You, Anytime
  • Please enter your first name.
  • Please enter your last name.
  • Please enter your phone number.
    This isn't a valid phone number.
  • Please enter your email address.
    This isn't a valid email address.
  • Please make a selection.
  • Please make a selection.
  • Please enter a message.
  • By submitting, you agree to receive text messages from Farrell & Fuller at the number provided, including those related to your inquiry, follow-ups, and review requests, via automated technology. Consent is not a condition of purchase. Msg & data rates may apply. Msg frequency may vary. Reply STOP to cancel or HELP for assistance. Acceptable Use Policy